The California Institute for Regenerative Medicine awarded $42.1 million for translational research projects. These projects target brain cancers, salivary gland conditions, and a rare metabolic disease. CIRM’s Translational program supports promising stem cell and gene projects. It helps teams complete key activities needed for clinical studies or broad use. These activities can involve therapeutic candidates, … Continue reading CIRM invests more than $42 million in translational research